Call for Abstract
8th World Congress on Breast Cancer & Therapies, will be organized around the theme “Delving into the Advances in Breast Cancer Research”
Breast Cancer Summit 2018 is comprised of 9 tracks and 55 sessions designed to offer comprehensive sessions that address current issues in Breast Cancer Summit 2018.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
At least one in nine women develops breast cancer at some stage in their life. About 48,000 cases occur in the United Kingdom every year. Mostly develops in women over the age of 50 but younger women are also sometimes affected. Breast cancer can also develop in men, but this is rare. Breast cancer develops from a cancerous cell which develops in the lining of a mammary duct or a lobule in one of the breasts. It follows the classic progression though it often becomes systemic or widespread in the early onset of the disease. During this period, the cancer may metastasize, or spread through lymphatics or blood stream to areas elsewhere in the body. If breast cancer spreads to vital organs of the body, its presence will compromise the function of those organs. Fatal death is the result of extreme case of vital organ function.
- Track 1-1 Breast cancer knowledge and Characteristics
- Track 1-2 Psychosocial support and Vocational counselling
- Track 1-3 Signs, symptoms & Stages of Breast Cancer
- Track 1-4 Risk factors for Breast Cancer, Genetics & Breast cancer Epidemiology
- Track 1-5 Inflammatory Breast cancer
- Track 1-6 Metastatic Breast Cancer
- Track 1-7 Luminal A and B Breast cancer
- Track 1-8 Ductal Carcinoma In Situ (DCIS)
- Track 1-9 Triple Negative Breast Cancer
- Track 1-10 Myths and Truths in Breast Cancer
All ladies should be educated by their human services supplier about the best screening choices for them. In spite of the fact that Breast growth screening can't counteract breast malignancy, it can discover breast disease early, when it is simpler to treat. Talk with your specialist about which breast screening tests are appropriate for you, and when you ought to have them. Mammograms are the most ideal approach to discover breast disease early. Having standard mammograms can bring down the danger of kicking the bucket from breast tumor. A Breast MRI utilizes magnets and radio waves to take photos of the Breast. X-ray is utilized alongside mammograms to screen ladies who are at high hazard for getting breast disease. Being acquainted with how your breasts look and feel can help you see manifestations, for example, irregularities, torment, or changes in size that might be of concern. These could incorporate changes found amid a breast self-exam. You ought to report any progressions that you notice to your specialist or human services supplier. Having a clinical breast exam or doing a breast self-exam has not been found to bring down the danger of fatality from breast malignancy.
- Track 2-1 Breast Magnetic Resonance Imaging
- Track 2-2 Mammography
- Track 2-3 Clinical breast exam and breast self-exam
- Track 2-4 Molecular Breast Imaging
- Track 2-5 Breast ultrasound
- Track 2-6 PEM and EIT
- Track 2-7 Pros and Cons of breast cancer screening.
Clinical implications and cancer nursing based on the rates of pain and other symptoms documented in the literature, changes in clinical practice are needed to reduce the symptom burden of residents with cancer. However, evidence-based practice standards have yet to be defined for the specific population of residents with cancer. Primary care and cancer nursing is a care delivery system that supports professional nursing practice. Within Primary Nursing, a therapeutic relationship is established between a registered nurse and an individual patient and his or her family.
- Track 3-1Professional and ethical understanding of Patients
- Track 3-2assessment and management of patients
- Track 3-3Multidisciplinary care
- Track 3-4Values and attitudes in relation to the care
- Track 3-5Psychological Support
- Track 4-1Phases of Trails
- Track 4-2Cohert and case studies
- Track 4-3Randomisation
- Track 4-4Screening and Prevention trials
- Track 4-5Pilot studies and feasibility studies
- Track 5-1Breast Cancer Treatment during Pregnancy
- Track 5-2Side Effects
- Track 5-3Medication
- Track 6-1Routine cancer genotyping
- Track 6-2Partial breast irradiation
- Track 6-3Proton beam radiation
- Track 6-4Limiting Lymphedema
- Track 6-5Surgical Advances
- Track 6-6Molecular Cancer Therapeutics
- Track 6-7Anti- angiogenesis, Genetic risk and genetic testing (BRCA etc.)
- Track 7-1Breast-Sparing Surgery
- Track 7-2Breast-conserving surgery or mastectomy
- Track 7-3Lymph node surgery
- Track 7-4Segmental mastectomy
- Track 7-5Breast Reconstruction Surgery
- Track 7-6Tissue Flap surgery
- Track 8-1Physical Exercise
- Track 8-2Diet
- Track 8-3Post-menopausal Therapy
- Track 8-4Women at High risk of Breast Cancer
- Track 8-5Breast cancer screening
- Track 8-6Breast Feeding
- Track 8-7Body Weight